Skip to main content Accessibility help
×
Hostname: page-component-5c6d5d7d68-pkt8n Total loading time: 0 Render date: 2024-08-15T13:30:18.209Z Has data issue: false hasContentIssue false

Chapter 26 - Vulvo Vaginitis, Candida (Yeast) Infection

from Section 2 - Infections in Pregnancy

Published online by Cambridge University Press:  11 October 2019

Adel Elkady
Affiliation:
Police Force Hospital, Cairo
Prabha Sinha
Affiliation:
Oman Medical College, Oman
Soad Ali Zaki Hassan
Affiliation:
Alexandria University
Get access

Summary

Vulvitis and vaginitis is defined as a spectrum of conditions that cause vulval and/or vaginal symptoms. Candida is the most common cause of vulvovaginal complaints for which women seek medical advice, especially during pregnancy.

Vulvovaginal candidiasis (VVC) is an opportunistic mucosal mycosis, and one of the most common causes of vulvovaginal itching and discharge caused by Candida species (C. albicans, C. glabrata. C. krusei, C. parapsilosis and C. tropicalis).

Candida albicans causes 80–90 per cent of vaginal fungal infection.

Ten to twenty per cent of reproductive-age women who harbour Candida species are asymptomatic and do not require therapy.

Vaginal candidiasis, commonly called ‘yeast infection, or moniliasis’, is relatively common during pregnancy (especially during the second trimester). with an estimated prevalence of 10–75 per cent.

Approximately 75 per cent of all pregnant women experience at least one episode of VVC during their lifetime, and 50 per cent of them suffer recurrent events.

Type
Chapter
Information
Infections in Pregnancy
An Evidence-Based Approach
, pp. 155 - 158
Publisher: Cambridge University Press
Print publication year: 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Eschenbach, DA Chronic vulvovaginal candidiasis. New Eng J Med. 2004; 351: 851–2.CrossRefGoogle ScholarPubMed
Omar, AA. Gram stain versus culture in the diagnosis of vulvovaginal candidiasis. East Mediter Health J. 2001; 7(6): 925–34.Google Scholar
British Association for Sexual Health and HIV. Management of vulvovaginal candidiasis. 2007.Google Scholar
Holland, J, Young, ML, Lee, O, Chen, C-A. Vulvovaginal carriage of yeasts other than Candida albicans. Sex Transm Infect. 2003; 79(3): 249–50.CrossRefGoogle ScholarPubMed
Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). National Guideline for the Management of Vulvovaginal Candidiasis. Sex Transm Infect. 1999; 75(suppl 1): S19.Google Scholar
Sobel JD. Vulvovaginal candidosis. Lancet. 2007; 369: 1961–71.Google Scholar
Xu, DJ, Sobel, JD Candida vulvovaginitis in pregnancy Curr Infect Dis Rep. 2004; 6: 56–9.Google Scholar
Maki, Y, Fujisaki, M, Sato, Y, Sameshima, H. Candida chorioamnionitis leads to preterm birth and adverse fetal-neonatal outcome. Can J Infect Dis Obstet Gynecol. 2017.Google Scholar
Roberts, CL, Algert, CS, Rickard, KL, Morris, JM. Treatment of vaginal candidiasis for the prevention of preterm birth: a systematic review and meta-analysis. Syst Rev. 2015; 4: 31.Google Scholar
Vedmedovska, N, Rezeberga, N, Donder, GGG. Is abnormal vaginal microflora a risk factor for intrauterine fetal growth restriction? Asian Pac J Reprod. 2015; 4(4): 313–16.Google Scholar
Chintaginjala, A, Seetharam, K. Congenital candidiasis. Indian Dermatol Online J. 2014; 5(suppl 1): S44–7.Google Scholar
Pappas, PG, Kauffman, CA, Andes, DR et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016; 62(4): e1-50.Google Scholar
Mølgaard-Nielsen, D, Svanström, H, Melbye, M et al. Association between use of oral fluconazole during pregnancy and risk of spontaneous abortion and stillbirth. JAMA. 2016; 315: 58.CrossRefGoogle ScholarPubMed
Czeizel, AE, Kazy, Z, Puhó, E. Population-based case-control teratologic study of topical miconazole. Congenit Anom. (Kyoto) 2004; 44: 41–5. Abstract.Google Scholar
Menegola, E, Broccia, ML, Di Renzo, F, Giavini, E. Antifungal triazoles induce malformations in vitro. Reprod Toxicol. 2011; 15: 421–7.Google Scholar
Fluconazole (Diflucan): Drug Safety Communication – FDA evaluating study examining use of oral fluconazole (Diflucan) in pregnancy. www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm497656.htm.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×